Erschienen in:
01.10.2001 | Adis New Drug Profile
Cisplatin/Epinephrine Injectable Gel
A Viewpoint by Ahmad Awada
verfasst von:
Ahmad Awada
Erschienen in:
Drugs & Aging
|
Ausgabe 10/2001
Einloggen, um Zugang zu erhalten
Excerpt
The preclinical and clinical development of cisplatin/epinephrine injectable gel (MPI 5010) suggests that this preparation of cisplatin may be useful for the treatment of locally advanced or locally recurrent breast cancer, head and neck tumours, oesophageal cancer, melanoma lesions and liver tumours (hepatocellular carcinoma and liver metastases). The intent of this treatment is clearly palliative and the antitumour effect, when seen, is limited to the tumour sites in which the drug is administered. …